Filing Details
- Accession Number:
- 0001127602-13-023465
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-25 19:42:19
- Reporting Period:
- 2013-07-23
- Filing Date:
- 2013-07-25
- Accepted Time:
- 2013-07-25 19:42:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1191702 | R John Moore | 3200 Walnut Street Boulder CO 80301 | Vp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-23 | 5,000 | $2.74 | 16,886 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-23 | 5,000 | $6.50 | 11,886 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-25 | 4,759 | $3.75 | 16,645 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-23 | 5,000 | $0.00 | 5,000 | $2.74 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-25 | 4,759 | $0.00 | 4,759 | $3.75 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,000 | 2020-03-31 | No | 4 | M | Direct | |
0 | 2013-08-01 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2012.
- The option vests in four equal annual installments beginning March 4, 2011.
- The option vested in four equal annual installments beginning July 1, 2004.